Stay updated with breaking news from Andreas Wallinder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GOTHENBURG, SE / ACCESSWIRE / May 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO's innovative heart technology is currently under investigation in a randomized controlled clinical trial
GOTHENBURG, SWEDEN / ACCESSWIRE / August 24, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO invites to its digital Capital Markets Day, September 21, 2022. Dag Andersson, CEO, and members
GOTHENBURG, SE / ACCESSWIRE / November 22, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)To further optimize the commercialization process for XVIVO's unique technologies, Jaya Tiwari has been
GuruFocus Article or News written by ACCESSWIRE and the topic is about: